Litecoin gets its first major treasury backer in MEI Pharma’s $100m play

2025-8-5 18:13

MEI Pharma, a clinical-stage biotech firm, just made an unexpected pivot, allocating nine figures to Litecoin as a treasury asset. With GSR advising and Charlie Lee on board, the move signals a growing institutional belief in crypto’s role beyond speculation.… origin »

Bitcoin price in Telegram @btc_price_every_hour

Pharma (XPH) на Currencies.ru

$ 0 (+0.00%)
Объем 24H $0
Изменеия 24h: 0.00 %, 7d: 0.00 %
Cегодня L: $0 - H: $0
Капитализация $0 Rank 99999
Доступно / Всего 0 XPH

pharma treasury litecoin mei charlie lee board

Источник: Cripyo.news

pharma treasury → Результатов: 5


Партнеры Currencies.ru



Реклама на Currencies.ru

Самое свежее на Currencies.ru

Litecoin: Is $74 the base for LTC’s next price move?

Litecoin [LTC] has stabilized after crowd-driven fear pushed sentiment sharply negative, yet price rebounded over 6% from the demand support zone. Retail commentary remains pessimistic across sociaThe post Litecoin: Is $74 the base for LTC’s next price move? appeared first on AMBCrypto.

What next for Litecoin's price after its $80-floor cracks?

On Thursday, 18 April, Bitcoin [BTC] bounced to $89.5k before sinking to post a new low of $84.5k. This volatility saw Litecoin's price [LTC] drop 7.5% in 5 hours, with the altcoin posting a new lowerThe post What next for Litecoin's price after its $80-floor cracks? appeared first on AMBCrypto.

Litecoin’s 14-year resilience meets weak demand – Will LTC wake up?

In a bid to find the most undervalued legacy coin, the Silver Standard report made the case for Litecoin. It pointed out that the Proof of Work Litecoin network has a fourteen-year uptime, a rising haThe post Litecoin’s 14-year resilience meets weak demand – Will LTC wake up? appeared first on AMBCrypto.